Literature DB >> 17143187

Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure.

Dagmara Hering1, Zbigniew Zdrojewski, Ewa Król, Tomas Kara, Wiesława Kucharska, Virend K Somers, Bolesław Rutkowski, Krzysztof Narkiewicz.   

Abstract

OBJECTIVE: Sympathetic activation may contribute to both cardiovascular morbidity and the progression of chronic kidney disease. The role of the chemoreceptors in determining sympathetic nerve discharge in patients with chronic renal failure (CRF) is unknown. We tested the hypothesis that tonic activation of excitatory chemoreceptor afferents contributes to the elevated sympathetic activity in patients with CRF.
METHODS: Utilizing a double-blind, randomized, vehicle-controlled design, we examined the effects of chemoreflex deactivation on muscle sympathetic nerve activity (MSNA). We compared effects of breathing 100% oxygen for 15 min with effects of breathing room air for 15 min in 12 stable patients with CRF and in 12 control individuals with similar age, gender, blood pressure and body mass index.
RESULTS: The baseline MSNA was elevated significantly in the patients with CRF as compared with the control individuals (50 +/- 2 vs 42 +/- 2 bursts/min; P < 0.05). Reductions in systolic blood pressure and pulse pressure in response to the administration of 100% oxygen were significantly different from those observed during administration of room air in patients with CRF. In patients with CRF, MSNA decreased by 29 +/- 7% (P < 0.01) during hyperoxia but did not change during administration of room air (5 +/- 6%; P = NS). By contrast, neither 100% oxygen or room air changed any measures in control individuals.
CONCLUSIONS: Tonic activation of excitatory chemoreflex afferents contributes to increased efferent sympathetic activity to muscle circulation and to blood pressure control in patients with CRF. These findings may have important implications for understanding mechanisms underlying the link between CRF and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17143187     DOI: 10.1097/HJH.0b013e3280102d92

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  24 in total

1.  Gene polymorphisms contributing to hypertension in immunoglobulin A nephropathy.

Authors:  Maki Shinzawa; Ryohei Yamamoto; Yasuyuki Nagasawa; Tatsuya Shoji; Yoshitsugu Obi; Tomoko Namba; Harumi Kitamura; Tetsuya Kaneko; Noriyuki Okada; Hirotsugu Iwatani; Atsushi Yamauchi; Yoshiharu Tsubakihara; Enyu Imai; Yoshitaka Isaka; Hiromi Rakugi
Journal:  Clin Exp Nephrol       Date:  2011-11-11       Impact factor: 2.801

2.  Hypertension: Renal denervation in chronic kidney disease.

Authors:  Peter J Blankestijn; Jaap A Joles
Journal:  Nat Rev Nephrol       Date:  2012-07-03       Impact factor: 28.314

3.  Exercise training attenuates chemoreflex-mediated reductions of renal blood flow in heart failure.

Authors:  Noah J Marcus; Carolin Pügge; Jai Mediratta; Alicia M Schiller; Rodrigo Del Rio; Irving H Zucker; Harold D Schultz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-05-22       Impact factor: 4.733

Review 4.  Role of the carotid body in the pathophysiology of heart failure.

Authors:  Harold D Schultz; Noah J Marcus; Rodrigo Del Rio
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

Review 5.  Angiotensin and carotid body chemoreception in heart failure.

Authors:  Harold D Schultz
Journal:  Curr Opin Pharmacol       Date:  2011-01-15       Impact factor: 5.547

Review 6.  Role of neurotransmitter gases in the control of the carotid body in heart failure.

Authors:  Harold D Schultz; Rodrigo Del Rio; Yanfeng Ding; Noah J Marcus
Journal:  Respir Physiol Neurobiol       Date:  2012-07-25       Impact factor: 1.931

7.  Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment?

Authors:  Alberto Giannoni; Gianluca Mirizzi; Alberto Aimo; Michele Emdin; Claudio Passino
Journal:  World J Cardiol       Date:  2015-12-26

Review 8.  Current Approaches to Quantifying Tonic and Reflex Autonomic Outflows Controlling Cardiovascular Function in Humans and Experimental Animals.

Authors:  Ibrahim M Salman
Journal:  Curr Hypertens Rep       Date:  2015-11       Impact factor: 5.369

9.  Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease.

Authors:  Jeanie Park; Vito M Campese; Niloofar Nobakht; Holly R Middlekauff
Journal:  J Appl Physiol (1985)       Date:  2008-10-09

Review 10.  The sympathetic nervous system in chronic kidney disease.

Authors:  Sebastian Ewen; Christian Ukena; Dominik Linz; Roland E Schmieder; Michael Böhm; Felix Mahfoud
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.